MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    The interplay between cholinergic activity, attention, and turning in Parkinson’s disease

    R. Morris, D. Martini, G. Mcbarron, M. Mancini, F. Horak (Portland, OR, USA)

    Objective: Explore how cholinergic activity (measured by short latency afferent inhibition [SAI]) and attention relate to quality of turning performance over a week of daily…
  • 2019 International Congress

    Relationship between cognitive performance and mobility in patients with Parkinson´s disease: A cross-sectional study

    N. Sousa, R. Macedo, S. Brucki (Salvador, Brazil)

    Objective: To investigate the relationships between cognitive ability (global and single domain-executive functions) and gait performance (balance, gait speed and mobility) in patients with Parkinson's…
  • 2019 International Congress

    Health associated quality of life (HAQL) and humor/cognitive complaints predict mortality in Parkinson’s disease (PD)

    P. Bugalho, R. Barbosa, F. Ladeira, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisbon, Portugal)

    Objective: To assess the value of motor (MS), non-motor symptoms (NMS), HAQL and activities of daily living (ADL) for predicting mortality in PD. Background: Parkinson’s…
  • 2019 International Congress

    Association of MRI-derived estimated brain age and cognitive ability in Parkinson’s disease

    K-L. Horne, R. Shoorangiz, L. Livingston, S. Grenfell, M. Almuqbel, B. Young, M. Pascoe, M. Livingstone, M. Macaskill, D. Myall, T. Pitcher, T. Anderson, J. Dalrymple-Alford, T. Melzer (Chrsitchurch, New Zealand)

    Objective: To characterise MRI-derived structural age-related brain health in Parkinson’s disease (PD) patients as a function of cognitive ability. Background: Normal ageing produces a stereotypical…
  • 2019 International Congress

    Neuroprotective and neurotrophic efficacy of Ginkgo biloba extracts against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

    P. Kashyap, S. Gupta (Darbhanga, India)

    Objective: The present study examined the potential neuroprotective and neurotrophic efficacy of GBE against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of HD…
  • 2019 International Congress

    Modulation of the Startle Response in REM Sleep Behavior Disorder

    M. Puligheddu, M. Figorilli, ML. Fantini, M. Carta, F. Traccis, R. Frau, P. Devoto, D. Pani, M. Bortolato (Salt Lake City, UT, USA)

    Objective: To detect changes in the modulation of the Startle Reflex induced by brainstem circuitry abnormalities both in isolated and PD related Rem Behaviour Disorder…
  • 2019 International Congress

    Baseline hyposmia and RBD symptoms are associated with faster, but differential, cognitive decline at 2 years in the PPMI study

    G. Nomikos, J. Xiao, M. Yang, V. Irzhevsky (Cambridge, MA, USA)

    Objective: To explore the potential role of baseline hyposmia and RBD symptoms on progression of cognitive decline at 2 years. Background: Cognitive decline in PD…
  • 2019 International Congress

    A Neuroscientific approach for MCI Characterization using a Motor and Cognitive Dual-Task

    G. Mancioppi, F. Fiorini, M. Timpano Sportiello, E. Rovini, F. Cavallo (Pontedera, Italy)

    Objective: To investigate the relationship between cognition and motion skills, through an innovative technological tool able to quantify gait parameters, while providing for a Motor…
  • 2019 International Congress

    Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease

    A. Abundes-Corona, A. Cervantes-Arriaga, R. Zerón-Martínez, R. Solís-Vivanco, O. Cárdenas-Saenz, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To identify if the Montreal Cognitive Assessment (MoCA) is a sensible tool to differentiate cognitive impairment profiles between patients with Essential Tremor (ET) and…
  • 2019 International Congress

    Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report

    A. Costantini, M. Tan, M. Lo, L. Leyland, H. Morris, R. Weil (London, United Kingdom)

    Objective: To relate visuo-perceptual performance with cognitive and genetic measures in Parkinson’s disease. Background: Dementia is a common occurrence in Parkinson’s disease (PD), affecting up…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley